- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Perspectives of Theranostics
Authors
Keywords
-
Journal
MOLECULES
Volume 26, Issue 8, Pages 2232
Publisher
MDPI AG
Online
2021-04-13
DOI
10.3390/molecules26082232
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- First clinical results for PSMA targeted alpha therapy using 225Ac-PSMA-I&T in advanced mCRPC patients
- (2020) Mathias Johannes Zacherl et al. JOURNAL OF NUCLEAR MEDICINE
- Effects of Repeated 131I-meta-iodobenzylguanidine Radiotherapy on Tumor Size and Tumor Metabolic Activities in Patients with Metastatic Neuroendocrine Tumors
- (2020) Keiichiro Yoshinaga et al. JOURNAL OF NUCLEAR MEDICINE
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer
- (2019) Wolfgang P. Fendler et al. JAMA Oncology
- 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial
- (2019) Jeremie Calais et al. LANCET ONCOLOGY
- Targeted Radionuclide Therapy for Patients with Metastatic Pheochromocytoma and Paraganglioma: From Low-Specific-Activity to High-Specific-Activity Iodine-131 Metaiodobenzylguanidine
- (2019) Camilo Jimenez et al. Cancers
- Molecular imaging and radionuclide therapy of paraganglioma and pheochromocytoma
- (2019) David Taieb et al. ENDOCRINE-RELATED CANCER
- Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates
- (2019) MaryBeth B. Culp et al. EUROPEAN UROLOGY
- Pheochromocytoma and Paraganglioma
- (2019) Hartmut P.H. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long term follow-up and outcomes of re-treatment in an expanded 50 patient single-center phase II prospective trial of Lutetium-177 (177Lu) PSMA-617 theranostics in metastatic castrate-resistant prostate cancer
- (2019) John Violet et al. JOURNAL OF NUCLEAR MEDICINE
- Aggregation-Induced Emission (AIE) Dots: Emerging Theranostic Nanolights
- (2018) Guangxue Feng et al. ACCOUNTS OF CHEMICAL RESEARCH
- Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity
- (2018) Ulrike Garske-Román et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 1
- (2018) Sophie Poty et al. JOURNAL OF NUCLEAR MEDICINE
- Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control
- (2018) Clemens Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- [ 177 Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
- (2018) Michael S Hofman et al. LANCET ONCOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Introduction of the targeted alpha therapy (with Radium-223) into clinical practice in Japan: learnings and implementation
- (2018) Makoto Hosono et al. ANNALS OF NUCLEAR MEDICINE
- The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy
- (2017) C. Chiesa et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
- (2017) Yong Du et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer
- (2017) Axel Bräuer et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617
- (2017) Hojjat Ahmadzadehfar et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Current treatment strategies for advanced prostate cancer
- (2017) Kazumasa Komura et al. INTERNATIONAL JOURNAL OF UROLOGY
- 177Lu-3BP-227 for Neurotensin Receptor 1–Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical Results
- (2017) Richard P. Baum et al. JOURNAL OF NUCLEAR MEDICINE
- Proof of Therapeutic Efficacy of a 177 Lu-Labeled Neurotensin Receptor 1 Antagonist in a Colon Carcinoma Xenograft Model
- (2017) Jörg Schulz et al. JOURNAL OF NUCLEAR MEDICINE
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress
- (2017) Paola Jimenez et al. Current Oncology Reports
- Theranostic DNAzymes
- (2017) Wenhu Zhou et al. Theranostics
- Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer
- (2016) Thomas Pyka et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Precision medicine in pheochromocytoma and paraganglioma: current and future concepts
- (2016) P. Björklund et al. JOURNAL OF INTERNAL MEDICINE
- Radiation Dosimetry for 177 Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions
- (2016) Shozo Okamoto et al. JOURNAL OF NUCLEAR MEDICINE
- Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases
- (2016) A. F. van den Hoven et al. JOURNAL OF NUCLEAR MEDICINE
- German Multicenter Study Investigating 177 Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
- (2016) Kambiz Rahbar et al. JOURNAL OF NUCLEAR MEDICINE
- 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy
- (2016) R. P. Baum et al. JOURNAL OF NUCLEAR MEDICINE
- 225Ac-PSMA-617 for PSMA-Targeted -Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer
- (2016) C. Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
- (2016) Bryan R. Haugen et al. THYROID
- Draft guidelines regarding appropriate use of 131I-MIBG radiotherapy for neuroendocrine tumors
- (2015) Seigo Kinuya et al. ANNALS OF NUCLEAR MEDICINE
- Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) M. Ducreux et al. ANNALS OF ONCOLOGY
- FDG PET Performed at Thyroid Remnant Ablation Has a Higher Predictive Value for Long-Term Survival of High-Risk Patients With Well-Differentiated Thyroid Cancer Than Radioiodine Uptake
- (2015) Florian C. Gaertner et al. CLINICAL NUCLEAR MEDICINE
- Metal nanoparticles: a theranostic nanotool against cancer
- (2015) Harshita Sharma et al. DRUG DISCOVERY TODAY
- Subacute haematotoxicity after PRRT with 177Lu-DOTA-octreotate: prognostic factors, incidence and course
- (2015) Hendrik Bergsma et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
- (2015) M. Eiber et al. JOURNAL OF NUCLEAR MEDICINE
- Neurotensin receptors in pancreatic ductal carcinomas
- (2015) Meike Körner et al. EJNMMI Research
- Phase II study of first-line131I-rituximab radioimmunotherapy in follicular non-Hodgkin lymphoma and prognostic18F-fluorodeoxyglucose positron emission tomography
- (2014) Andrew D. McQuillan et al. LEUKEMIA & LYMPHOMA
- Advances in Anticancer Radiopharmaceuticals
- (2013) M.R. Jackson et al. CLINICAL ONCOLOGY
- Radioimmunotherapy with 177Lu-DOTA-Rituximab: Final Results of a Phase I/II Study in 31 Patients with Relapsing Follicular, Mantle Cell, and Other Indolent B-Cell Lymphomas
- (2013) F. Forrer et al. JOURNAL OF NUCLEAR MEDICINE
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH
- (2012) A. Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- International Variation in Prostate Cancer Incidence and Mortality Rates
- (2012) Melissa M. Center et al. EUROPEAN UROLOGY
- Concepts, Consequences, and Implications of Theranosis
- (2012) Gerald L. DeNardo et al. SEMINARS IN NUCLEAR MEDICINE
- Effective use of strontium-89 in osseous metastases
- (2011) Isao Kuroda ANNALS OF NUCLEAR MEDICINE
- The Local Efficacy of I-131 for F-18 FDG PET Positive Lesions in Patients With Recurrent or Metastatic Thyroid Carcinomas
- (2011) Kotaro Yoshio et al. CLINICAL NUCLEAR MEDICINE
- Clinical significance of 2-[18F]fluoro-2-deoxy-d-glucose positron emission tomography for the assessment of 131I-metaiodobenzylguanidine therapy in malignant phaeochromocytoma
- (2011) Azusa Nakazawa et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Radioimmunotherapy of relapsed indolent non-Hodgkin lymphoma with 131I-rituximab in routine clinical practice: 10-year single-institution experience of 142 consecutive patients
- (2010) M. F. Leahy et al. BLOOD
- Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?
- (2010) D. Deandreis et al. ENDOCRINE-RELATED CANCER
- Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators
- (2010) Montserrat Ayala-Ramirez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy
- (2008) Francesco Giammarile et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Guidelines for radioiodine therapy of differentiated thyroid cancer
- (2008) M. Luster et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search